Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

TWD 70.7

(-3.42%)

Operating Expenses Summary of Johnson Chemical Pharmaceutical Works Co., Ltd.

  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest annual operating expenses in 2023 was 244.63 Million TWD , up 19.73% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 37.54 Million TWD , down -4.35% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a annual operating expenses of 121.7 Million TWD in annual operating expenses 2022, up 11.0% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a annual operating expenses of 109.63 Million TWD in annual operating expenses 2021, down -6.01% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly operating expenses of 39.24 Million TWD for 2024 Q1, down -2.56% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly operating expenses of 40.28 Million TWD for 2023 Q4, up 13.42% from previous quarter.

Annual Operating Expenses Chart of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 244.63 Million TWD 19.73%
2022 121.7 Million TWD 11.0%
2021 109.63 Million TWD -6.01%
2020 116.65 Million TWD 3.59%
2019 112.61 Million TWD 0.0%

Peer Operating Expenses Comparison of Johnson Chemical Pharmaceutical Works Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Allied Biotech Corporation 157.72 Million TWD -55.101%
GeneFerm Biotechnology Co., Ltd. 132.78 Million TWD -84.231%
Easywell Biomedicals, Inc. 333.45 Million TWD 26.637%
TTY Biopharm Company Limited 1.91 Billion TWD 87.203%
Synmosa Biopharma Corporation 1.49 Billion TWD 83.687%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 88.607%
Center Laboratories, Inc. 697.35 Million TWD 64.92%
Tien Liang BioTech Co., Ltd. 267.27 Million TWD 8.471%
Orient Pharma Co., Ltd. 468.66 Million TWD 47.802%
InnoPharmax Inc. 82.29 Million TWD -197.26%
Excelsior Biopharma Inc. 388.05 Million TWD 36.96%
DV Biomed Co., Ltd. 575.24 Million TWD 57.473%
Foresee Pharmaceuticals Co., Ltd. 1.12 Billion TWD 78.189%
Handa Pharmaceuticals, Inc. 399.14 Million TWD 38.711%
UniPharma Co., Ltd. 78.32 Million TWD -212.347%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 38.369%
Alar Pharmaceuticals Inc. 83.74 Million TWD -192.117%
Winston Medical Supply Co., Ltd. 151.49 Million TWD -61.477%
Mercury Biopharmaceutical Corporation 592 Thousand TWD -41223.142%
Bioray Biotech Co., Ltd 96.98 Million TWD -152.246%
TSH Biopharm Corporation Limited 336.26 Million TWD 27.251%